Your browser doesn't support javascript.
Convalescent Plasma Therapy for COVID-19: State of the Art.
Focosi, Daniele; Anderson, Arthur O; Tang, Julian W; Tuccori, Marco.
  • Focosi D; North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy daniele.focosi@gmail.com.
  • Anderson AO; Department of Respiratory Mucosal Immunity, US Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
  • Tang JW; Respiratory Sciences, University of Leicester, Leicester, United Kingdom.
  • Tuccori M; Division of Pharmacology and Pharmacovigilance, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Clin Microbiol Rev ; 33(4)2020 09 16.
Article in English | MEDLINE | ID: covidwho-721176
ABSTRACT
Convalescent plasma (CP) therapy has been used since the early 1900s to treat emerging infectious diseases; its efficacy was later associated with the evidence that polyclonal neutralizing antibodies can reduce the duration of viremia. Recent large outbreaks of viral diseases for which effective antivirals or vaccines are still lacking has renewed the interest in CP as a life-saving treatment. The ongoing COVID-19 pandemic has led to the scaling up of CP therapy to unprecedented levels. Compared with historical usage, pathogen reduction technologies have now added an extra layer of safety to the use of CP, and new manufacturing approaches are being explored. This review summarizes historical settings of application, with a focus on betacoronaviruses, and surveys current approaches for donor selection and CP collection, pooling technologies, pathogen inactivation systems, and banking of CP. We additionally list the ongoing registered clinical trials for CP throughout the world and discuss the trial results published thus far.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal subject: Microbiology Year: 2020 Document Type: Article Affiliation country: CMR.00072-20

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal subject: Microbiology Year: 2020 Document Type: Article Affiliation country: CMR.00072-20